MARKET

TELO

TELO

Telomir Pharms
NASDAQ
0.5475
-0.0475
-7.98%
Opening 13:33 11/12 EST
OPEN
0.5950
PREV CLOSE
0.5950
HIGH
0.6299
LOW
0.5450
VOLUME
100.63K
TURNOVER
--
52 WEEK HIGH
1.580
52 WEEK LOW
0.5450
MARKET CAP
40.34M
P/E (TTM)
-0.6013
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TELO last week (1102-1106)?
Weekly Report · 3d ago
Weekly Report: what happened at TELO last week (1026-1030)?
Weekly Report · 11/02 09:13
Telomir registers to sell 5.29M shares of common stock for holders
TipRanks · 10/27 20:43
Weekly Report: what happened at TELO last week (1019-1023)?
Weekly Report · 10/26 09:13
Weekly Report: what happened at TELO last week (1012-1016)?
Weekly Report · 10/19 09:13
Weekly Report: what happened at TELO last week (1005-1009)?
Weekly Report · 10/12 09:14
Telomir Raises PIPE Financing to Fund Oncology Trials
TipRanks · 10/06 12:35
Telomir Pharmaceuticals Announces ~$5.6M Investment In PIPE Financing Through Common Stock Issuance
Benzinga · 10/06 12:10
More
About TELO
Telomir Pharmaceuticals, Inc. is a biotechnology company developing small-molecule therapeutics designed to target epigenetic and metabolic mechanisms implicated in cancer, aging, and degenerative disease. The Company's lead candidate, Telomir-1 (Telomir-Zn), is an investigational therapy that has demonstrated activity in preclinical studies involving modulation of intracellular metal homeostasis, epigenetic regulation, mitochondrial function, and genomic stability. Telomir-1 is an oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 may help protect against age related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease, and Age-related Macular Degeneration (AMD), as well as Type 2 diabetes, breast cancer, and Alzheimer’s disease.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.